Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041768 | SCV000065464 | likely benign | not specified | 2014-12-17 | criteria provided, single submitter | clinical testing | p.Thr4888Thr in exon 67 of USH2A: This variant is not expected to have clinical significance because it does not alter an amino acid residue and is not located near a splice junction. It has been identified in 0.1% (73/67624) of European ch romosomes by the Exome Aggregation Consortium (http://exac.broadinstitute.org; d bSNP rs111033525). |
Eurofins Ntd Llc |
RCV000725431 | SCV000336889 | uncertain significance | not provided | 2018-03-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000725431 | SCV001049825 | likely benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000725431 | SCV001473247 | benign | not provided | 2019-11-16 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000725431 | SCV001500876 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | USH2A: BP4, BP7 |
Gene |
RCV000725431 | SCV001802157 | likely benign | not provided | 2019-09-19 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001272930 | SCV001455381 | uncertain significance | Usher syndrome type 2A | 2020-01-08 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV000725431 | SCV002034608 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000725431 | SCV002038141 | likely benign | not provided | no assertion criteria provided | clinical testing |